{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T20:25:18Z","timestamp":1783974318269,"version":"3.55.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:00:00Z","timestamp":1695340800000},"content-version":"am","delay-in-days":356,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progr\u00e8s en Urologie"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.purol.2022.05.004","type":"journal-article","created":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T07:56:16Z","timestamp":1656402976000},"page":"856-861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Tolerance and efficacy of platelet-rich plasma injections in Peyronie's disease: Pilot study"],"prefix":"10.1016","volume":"32","author":[{"given":"A.","family":"Schirmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Boutin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Faix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Yiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.purol.2022.05.004_bib0110","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.purol.2020.11.004","article-title":"French Urological Association (AFU) guidelines for Peyronie's disease assessment and treatment","volume":"31","author":"Ferretti","year":"2021","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2022.05.004_bib0115","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/sj.ijir.3900863","article-title":"Epidemiology of Peyronie's disease","volume":"14","author":"Sommer","year":"2002","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.purol.2022.05.004_bib0120","doi-asserted-by":"crossref","first-page":"602","DOI":"10.5435\/00124635-200910000-00002","article-title":"Platelet-rich plasma: current concepts and application in sports medicine","volume":"17","author":"Hall","year":"2009","journal-title":"J Am Acad Orthop Surg"},{"key":"10.1016\/j.purol.2022.05.004_bib0125","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1902\/jop.2007.060302","article-title":"Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties","volume":"78","author":"El-Sharkawy","year":"2007","journal-title":"J Periodontol"},{"key":"10.1016\/j.purol.2022.05.004_bib0130","first-page":"2578","article-title":"Effect of platelet rich plasma on the regeneration of cavernous nerve: experiment with rats","volume":"88","author":"Ding","year":"2008","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.purol.2022.05.004_bib0135","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1111\/j.1743-6109.2012.02881.x","article-title":"The neuroprotective effect of platelet-rich plasma on erectile function in bilateral cavernous nerve injury rat model","volume":"9","author":"Wu","year":"2012","journal-title":"J Sex Med"},{"key":"10.1016\/j.purol.2022.05.004_bib0140","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.juro.2013.01.087","article-title":"Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies","volume":"190","author":"Gelbard","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2022.05.004_bib0145","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s40265-015-0441-7","article-title":"Collagenase clostridium histolyticum: a review in Peyronie's disease","volume":"75","author":"Dhillon","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.purol.2022.05.004_bib0150","article-title":"Collagenase clostridium histolyticum: a review in Peyronie's disease","author":"Hoy","year":"2019","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.purol.2022.05.004_bib0155","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.purol.2020.05.002","article-title":"Biotherapies for erectile dysfunction and Peyronie's disease: where are we now?","volume":"16","author":"Akakpo","year":"2020","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2022.05.004_bib0160","doi-asserted-by":"crossref","first-page":"e000060","DOI":"10.1136\/bmjsem-2015-000060","article-title":"DEPA classification: a proposal for standardising PRP use and a retrospective application of available devices","volume":"2","author":"Magalon","year":"2016","journal-title":"BMJ Open Sport Exerc Med"},{"key":"10.1016\/j.purol.2022.05.004_bib0165","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.purol.2013.02.012","article-title":"[Lapeyronie's disease]","volume":"23","author":"Ferretti","year":"2013","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2022.05.004_bib0170","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0090-4295(97)00238-0","article-title":"The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction","volume":"49","author":"Rosen","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.purol.2022.05.004_bib0175","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.urology.2006.06.027","article-title":"Erectile function and assessments of erection hardness correlate positively with measures of emotional well-being, sexual satisfaction, and treatment satisfaction in men with erectile dysfunction treated with sildenafil citrate (Viagra)","volume":"68","author":"Montorsi","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.purol.2022.05.004_bib0180","first-page":"1","article-title":"Evaluation of the benefit of using a combination of autologous platelet rich-plasma and hyaluronic acid for the treatment of Peyronie's disease","author":"Virag","year":"2017","journal-title":"Sex Health Issues"},{"key":"10.1016\/j.purol.2022.05.004_bib0185","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4111\/icu.2018.59.1.61","article-title":"Safety and feasibility of platelet rich fibrin matrix injections for treatment of common urologic conditions","volume":"59","author":"Matz","year":"2018","journal-title":"Investig Clin Urol"},{"key":"10.1016\/j.purol.2022.05.004_bib0190","doi-asserted-by":"crossref","first-page":"280","DOI":"10.21037\/tau.2016.04.05","article-title":"Peyronie's disease: a literature review on epidemiology, genetics, pathophysiology, diagnosis and work-up","volume":"5","author":"Al-Thakafi","year":"2016","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.purol.2022.05.004_bib0195","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0022-5347(01)65361-8","article-title":"Proposal: trauma as the cause of the Peyronie's lesion","volume":"157","author":"Devine","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2022.05.004_bib0200","first-page":"35S","article-title":"Platelet rich plasma therapy: inflammatory molecules involved in tissue healing","volume":"26","author":"Galliera","year":"2012","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.1016\/j.purol.2022.05.004_bib0205","first-page":"3532","article-title":"Platelets and wound healing","volume":"13","author":"Nurden","year":"2008","journal-title":"Front Biosci J Virtual Libr"},{"key":"10.1016\/j.purol.2022.05.004_bib0210","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1152\/physrev.2003.83.3.835","article-title":"Regulation of wound healing by growth factors and cytokines","volume":"83","author":"Werner","year":"2003","journal-title":"Physiol Rev"}],"container-title":["Progr\u00e8s en Urologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708722001324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708722001324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:35:58Z","timestamp":1761114958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1166708722001324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":21,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1166708722001324"],"URL":"https:\/\/doi.org\/10.1016\/j.purol.2022.05.004","relation":{},"ISSN":["1166-7087"],"issn-type":[{"value":"1166-7087","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tolerance and efficacy of platelet-rich plasma injections in Peyronie's disease: Pilot study","name":"articletitle","label":"Article Title"},{"value":"Progr\u00e8s en Urologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2022.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}